March 24, 2017
Nordic Nanovector: - Nordic Nanovector publishes Annual Report 2016
(Press Release 9/2017). See link for details
See: Annual Report 2016

March 17, 2017
Nordic Nanovector: - Nordic Nanovector announces first patient dosed in Phase 1 study of Betalutin® in diffuse large B-cell lymphoma (DLBCL), an aggressive form of NHL
(Press Release 8/2017 ). See link for details

February 28, 2017
Nordic Nanovector: - Nordic Nanovector ASA – Results for Fourth Quarter and Full Year 2016
(Press Release 6/2017). See link for details
See: Q416 report 2016
See: Q4 16 presentation 2016

February 28, 2017
Nordic Nanovector: - Nordic Nanovector ASA – resultater for fjerde kvartal og helår 2016
(Press Release 7/2017). See link for details
See: Q4 16 presentation 2016
See: Q416 report 2016

February 22, 2017
Nordic Nanovector: - Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2016 Results Presentation and Webcast
(Press Release 5/2017). See link for details

February 2, 2017
Nordic Nanovector: - Nordic Nanovector ASA: Share capital increase registered
(Press Release 4/2017). See link for details

February 2, 2017
Nordic Nanovector: - Nordic Nanovector: Share options granted, including options to primary insiders
(Press Release 3/2017). See link for details

January 24, 2017
Nordic Nanovector: - Nordic Nanovector ASA: Exercise of employee share options and increase of share capital
(Press Release 2/2017). See link for details

January 4, 2017
Nordic Nanovector: - Nordic Nanovector to Present at Biotech Showcase 2017
(Press Release 1/2017). See link for details